Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized d-limonene and THC administered via inhalation.


Clinical Trial Description

The proposed study will be conducted at the Johns Hopkins Behavioral Pharmacology Research Unit (BPRU). Participants will complete 9 acute drug administration periods in which they will administer THC alone, limonene alone, THC and limonene together, or placebo. Subjective drug effects and vital signs will be assessed following drug administration. Each participant will receive all 9 dose conditions in a randomized order using a placebo controlled within-subject crossover design. The study will help us understand the individual and interactive effects of THC and d-limonene, two common constituents found in cannabis. ;


Study Design


Related Conditions & MeSH terms

  • D-limonene and THC Pharmacodynamics

NCT number NCT03609853
Study type Interventional
Source Johns Hopkins University
Contact
Status Completed
Phase Phase 1
Start date April 1, 2019
Completion date October 25, 2023